CIK 0001641631 · Non-accelerated filer<br>Smaller reporting company
Beyond Air, Inc.
Sign in to watch- Ticker
- XAIR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Mar 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473812456
- Phone
- 516-665-8200
- Business address
- 900 STEWART AVENUE, SUITE 301, GARDEN CITY, NY, 11530
- Former names
- AIT Therapeutics, Inc., KokiCare, Inc.
- Open-market buys, last 90 days
- $62,352
- in 2 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$62,352. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-11-03 | Carey Robert Director | Returned to the company · Warrants to purchase Common Stock | −494,332 | 0 | ||
| 2025-11-03 | Carey Robert Director | Grant or award · Warrants to purchase Common Stock | +494,332 | 494,332 | ||
| 2025-11-03 | Lisi Steven A. CEO and Chairman of the Board | Returned to the company · Warrants to purchase Common Stock | −164,778 | 0 | ||
| 2025-11-03 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Warrants to purchase Common Stock | +164,778 | 164,778 | ||
| 2025-08-14 | Goodman Robert Scott Director | Grant or award · Stock Options (Right to buy) | +3,750 | 5,750 | ||
| 2025-07-21 | Lisi Steven A. CEO and Chairman of the Board | Purchase | +6,000 | $3.25 | $19K | 3,327,411 |
| 2025-03-26 | Lucera Erick Director | Grant or award · Stock Options (Right to buy) | +75,000 | 75,000 | ||
| 2025-03-26 | Lisi Steven A. CEO and Chairman of the Board | Grant or award · Stock Options (Right to buy) | +950,000 | 950,000 | ||
| 2025-03-26 | Lee Yoori Director | Grant or award · Stock Options (Right to buy) | +75,000 | 75,000 | ||
| 2025-03-26 | Gaul Michael A. Chief Operating Officer | Grant or award · Stock Options (Right to buy) | +400,000 | 400,000 | ||
| 2025-03-26 | Carey Robert Director | Grant or award · Stock Options (Right to buy) | +200,000 | 200,000 | ||
| 2025-03-26 | Larson Douglas Quinton Chief Financial Officer | Grant or award · Stock Options (Right to buy) | +350,000 | 350,000 | ||
| 2025-03-26 | Forbes William P Director | Grant or award · Stock Options (Right to buy) | +75,000 | 75,000 | ||
| 2025-03-14 | Carey Robert Director | Purchase | +990,000 | $0.25 | $248K | 4,066,864 |
| 2025-03-14 | Carey Robert Director | Purchase | +10,000 | $0.26 | $3K | 4,076,864 |
| 2025-02-19 | Gaul Michael A. Chief Operating Officer | Purchase | +6,000 | $0.38 | $2K | 94,150 |
| 2024-11-22 | Gaul Michael A. Chief Operating Officer | Returned to the company · Stock Options (Right to buy) | −350,000 | 0 | ||
| 2024-11-22 | Gaul Michael A. Chief Operating Officer | Grant or award · Stock Options (Right to buy) | +350,000 | 350,000 | ||
| 2024-11-22 | Gaul Michael A. Chief Operating Officer | Returned to the company · Stock Options (Right to buy) | −170,000 | 0 | ||
| 2024-11-22 | Gaul Michael A. Chief Operating Officer | Grant or award · Stock Options (Right to buy) | +170,000 | 170,000 |
Page 7 of 17 · 328 trades